Quadramed Corp - Current report filing (8-K)
July 22 2008 - 9:52AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 17, 2008
QuadraMed Corporation
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
001-32283
|
|
52-1992861
|
(State or Other Jurisdiction
of Incorporation)
|
|
(Commission File Number)
|
|
(I.R.S. Employer
Identification No.)
|
12110 Sunset Hills Road, Suite 600, Reston, VA 20190
(Address of principal executive office and zip code)
(703) 709-2300
(Registrants telephone number, including area code)
(Not Applicable)
(Former name or
former address, if changed since last report)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
TABLE OF CONTENTS
2
ITEM 5.02
|
DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS.
|
On July 17, 2008, the Board of Directors of QuadraMed Corporation (the Company) approved a policy under which the Company will offer to repurchase
shares of restricted stock granted to the Companys employees on the date such shares vest; however, such repurchase shall be limited to an amount sufficient to permit the applicable employee to pay taxes on such shares.
3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Date: July 22, 2008
|
QuadraMed Corporation
|
|
/s/ David L. Piazza
|
David L. Piazza
|
Executive Vice President and Chief Financial Officer
|
4
Quadramed Corp (MM) (NASDAQ:QDHC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Quadramed Corp (MM) (NASDAQ:QDHC)
Historical Stock Chart
From Jul 2023 to Jul 2024